What you need to know
Five new physicians have joined the medical staff at John Theurer Cancer Center at Hackensack University Medical Center.
Hyung C. Suh, M.D., Ph.D, Gurbakhash Kaur, M.D., Gurbakhash Kaur, M.D., Andrew Ip, M.D., MS and Kaushal Parikh, MBBS will bolster the center’s stem cell transplantation, blood cancer, and thoracic cancer programs.
More details about the physicians
Hyung C. Suh, M.D., Ph.D, is a hematologist-oncologist who joined the Stem Cell Transplantation and Cellular Therapy program. Dr. Suh specializes in the care of people with blood cancers (such as leukemia, lymphoma, and multiple myeloma) and in the use of stem cell transplantation, cellular therapy, and immunotherapy to treat these cancers. He is also an experienced biomedical scientist with expertise in hematology-oncology research and the translation of research findings from the laboratory to the patients they may help.
Gurbakhash Kaur, M.D., is a hematologist-oncologist who specializes in hematology-oncology, especially the treatment of multiple myeloma. She is especially interested in the application of novel immunotherapies to treat cancer, including multiple myeloma.
Sukhdeep Kaur, M.D., is a hematologist-oncologist who specializes in stem cell transplantation — including allogeneic transplants (from a donor) and autologous (“self”) transplants — for blood cancers and blood diseases. She also oversees the use of cellular therapies in patients, including CAR T-cell therapy — an innovative treatment which trains a patient’s white blood cells (called T cells) to find and destroy cancer cells.
Andrew Ip, M.D., MS, is a hematologist-oncologist who specializes in the care of patients with lymphoma and multiple myeloma. In his research, Dr. Ip is part of John Theurer Cancer Center’s Outcomes Division. He is interested in utilizing population science to see the “big picture” of cancer care in order to enhance the lives of patients and their families. He also has an interest in using digital health technology to promote improved cancer outcomes, having piloted an Apple Watch physical activity intervention for people with cancer.
Kaushal Parikh, MBBS, is a medical oncologist who specializes in the treatment of patients with thoracic cancers, such as lung cancer, thymoma, and mesothelioma. He is also involved in drug development and early-phase clinical trials, particularly through John Theurer Cancer Center’s robust Phase I clinical trials program. He and his colleagues are working to expand the translational research program so that more findings from the laboratory can be translated to the clinic to help patients.